Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06673108 · ClinicalTrials.gov registry record · Phase 2

Vaginal Photobiomodulation for Chronic Pelvic Pain

A Phase 2 study of Chronic Pelvic Pain and Chronic Pelvic Pain Syndrome (CPPS), sponsored by SoLa Pelvic Therapy.

Recruiting
Registry status
Phase 2
Development phase
126
Enrollment target
5
Study locations

NCT06673108: Recruiting Phase 2 study of Chronic Pelvic Pain and Chronic Pelvic Pain Syndrome (CPPS), sponsored by SoLa Pelvic Therapy.

NCT06673108 is a Phase 2 study of Chronic Pelvic Pain and Chronic Pelvic Pain Syndrome (CPPS) that is actively recruiting participants, run by SoLa Pelvic Therapy. The registered enrollment target is 126 participants, below the 321-participant average among 8 other Chronic Pelvic Pain trials with a reported enrollment target (61% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06673108, a Phase 2 study of Chronic Pelvic Pain and Chronic Pelvic Pain Syndrome (CPPS), is actively recruiting participants, sponsored by SoLa Pelvic Therapy.

RECRUITING
Registry status
Phase 2
Development phase
126 participants
Enrollment target
5
Study locations

Study Summary

The goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women. Additionally, researchers want to determine if treatment with this type of energy can also alleviate pain with activities such as standing, sitting, urinating, having bowel movements and intercourse.

Primary Outcome

Overall pelvic pain level as measured on a 0-10 numeric rating pain scale (NRPS). On this scale, 0 represents no pain and 10 represents wors pain possible. Pain will be analyzed as median pain levels and % of participants achieving a minimal clinically important difference (MCID) defined as reduction in pain level of 2 or more NRPS points.

Interventions

  • DEVICE SoLa Pelvic Therapy

Study Locations (5)

Alabama

  • Obgyn South - Birmingham

California

  • The Orady Womens Clinic - San Francisco

Kansas

  • Urogynecology of Kansas City - Overland Park

Massachusetts

  • Boston Urogyn - Boston

Texas

  • Nurture Women's Health - Frisco

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2024-10-17
Est. Completion 2026-06
Phase Phase 2
SoLa Pelvic Therapy

1 total trials

What NCT06673108 shows while recruiting

NCT06673108 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 321-participant average among 8 other Chronic Pelvic Pain trials with a reported enrollment target (61% lower).

The record links to 2 conditions, with Chronic Pelvic Pain appearing as the primary indexed condition, and to 1 intervention - of which SoLa Pelvic Therapy is the first listed.

NCT06673108 lists 5 locations in 5 states (Alabama, California, Kansas).

Frequently Asked Questions

What is clinical trial NCT06673108 about?

NCT06673108 is a clinical study titled "Vaginal Photobiomodulation for Chronic Pelvic Pain". The goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women. Additionally, researchers want to determine if treatment with this type of energy can also alleviate pain with activities such as sta...

What is the current status of trial NCT06673108?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2024-10-17. Estimated completion is 2026-06.

What conditions does trial NCT06673108 study?

This clinical trial studies the following conditions: Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome (CPPS).

What interventions are being tested in trial NCT06673108?

The interventions under investigation include: SoLa Pelvic Therapy (DEVICE).

Who is sponsoring clinical trial NCT06673108?

This trial is sponsored by SoLa Pelvic Therapy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06673108 being conducted?

This trial has 5 study locations across Alabama, California, Kansas, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pelvic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06673108's enrollment target sits among peer trials

126 4th of 8 higher than 5 of 8 other Chronic Pelvic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pelvic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06673108, the US trial registry maintained by the National Library of Medicine. NCT06673108 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.